|
MET
|
11 nmol/L
|
Cell-based assays
|
Download PDF
|
|
SU-DIPG-36 cells
|
31.54 µM
|
Multi-well crystal violet (CV) assay
|
Download PDF
|
|
First pATC culture with STRN–ALK fusion
|
72 nM
|
WST-1 assay, cell counting, Hoechst 33342 staining, Annexin V staining, Transwell Permeable Supports (migration/invasion)
|
Download PDF
|
|
Second pATC culture with STRN–ALK fusion
|
85 nM
|
WST-1 assay, cell counting, Hoechst 33342 staining, Annexin V staining, Transwell Permeable Supports (migration/invasion)
|
Download PDF
|
|
pATC culture without STRN–ALK fusion
|
112 nM
|
WST-1 assay, cell counting, Hoechst 33342 staining, Annexin V staining, Transwell Permeable Supports (migration/invasion)
|
Download PDF
|
|
Mlg cells
|
7.45 μM
|
MTT assay
|
PMC12972922
|
|
MUG-Chor1
|
4.57 µM
|
non-linear regression with a four-parameter logistic model, viability measured by metabolic ATP levels (assay)
|
Download PDF
|
|
U-CH2
|
6.79 µM
|
non-linear regression with a four-parameter logistic model, viability measured by metabolic ATP levels (assay)
|
Download PDF
|
|
ADK-VR2
|
4 nM
|
interpolation of the growth percentages with a sigmoid dose-response curve by Prism 5 software and IC50 Calculator | AAT Bioquest
|
PMC9742620
|
|
ADK-VR2 AG143
|
23.6 nM
|
interpolation of the growth percentages with a sigmoid dose-response curve by Prism 5 software and IC50 Calculator | AAT Bioquest
|
PMC9742620
|
|
NL20 cells (EML4-ALK V3a)
|
234.8 ± 10.8 nM
|
Dose-dependent ALK activity responses followed with anti-pALK-Y1604 as readout, inhibition curves generated from immunoblotting results, and IC50 values calculated by fitting data to a log (inhibitor concentration) vs. normalized response (variable slope)
|
Download PDF
|
|
NL20 cells (EML4-ALK V3b)
|
94.8 ± 4.5 nM
|
Dose-dependent ALK activity responses followed with anti-pALK-Y1604 as readout, inhibition curves generated from immunoblotting results, and IC50 values calculated by fitting data to a log (inhibitor concentration) vs. normalized response (variable slope)
|
Download PDF
|
|
NL20 cells (EML4-ALK (F1174S) V3a)
|
66.1 ± 0.8 nM
|
Dose-dependent ALK activity responses followed with anti-pALK-Y1604 as readout, inhibition curves generated from immunoblotting results, and IC50 values calculated by fitting data to a log (inhibitor concentration) vs. normalized response (variable slope)
|
Download PDF
|
|
NL20 cells (EML4-ALK (F1174S) V3b)
|
71.1 ± 6.1 nM
|
Dose-dependent ALK activity responses followed with anti-pALK-Y1604 as readout, inhibition curves generated from immunoblotting results, and IC50 values calculated by fitting data to a log (inhibitor concentration) vs. normalized response (variable slope)
|
Download PDF
|
|
MDA-MB-231 parental cells
|
2.14 μM
|
Cell viability assay
|
Download PDF
|
|
MDA-MB-231-R
|
11.3 μM
|
Cell viability assay
|
Download PDF
|
|
Hs578T parental cells
|
3.283 μM
|
Cell viability assay
|
Download PDF
|
|
Hs578T-R
|
17.71 μM
|
Cell viability assay
|
Download PDF
|
|
H3122
|
0.008 μM
|
assay
|
PMC9633314
|
|
RBE
|
5.572 µM
|
WST-1 assay; GraphPad Prism 5 (nonlinear curve fit of Y = 100/(1 + 10((Log10IC50-X)*HillSlope)))
|
Download PDF
|
|
TFK-1
|
12.79 µM
|
WST-1 assay; GraphPad Prism 5 (nonlinear curve fit of Y = 100/(1 + 10((Log10IC50-X)*HillSlope)))
|
Download PDF
|
|
HuCCA-1
|
3.711 µM
|
WST-1 assay; GraphPad Prism 5 (nonlinear curve fit of Y = 100/(1 + 10((Log10IC50-X)*HillSlope)))
|
Download PDF
|
|
KKU-M055
|
11.59 µM
|
WST-1 assay; GraphPad Prism 5 (nonlinear curve fit of Y = 100/(1 + 10((Log10IC50-X)*HillSlope)))
|
Download PDF
|
|
KKU-M156
|
6.25 µM
|
WST-1 assay; GraphPad Prism 5 (nonlinear curve fit of Y = 100/(1 + 10((Log10IC50-X)*HillSlope)))
|
Download PDF
|
|
Ba/F3 cells expressing BCR-ABL1 Y253F
|
200-250 nM
|
XTT assay
|
Download PDF
|
|
Ba/F3 cells expressing BCR-ABL1 F317L
|
200-250 nM
|
XTT assay
|
Download PDF
|
|
BV-173
|
50 nM
|
XTT assay
|
Download PDF
|
|
SupB15
|
150 nM
|
XTT assay
|
Download PDF
|
|
PH PD-LTCs
|
50-100 nM
|
XTT assay
|
Download PDF
|
|
BV PD-LTCs
|
50-100 nM
|
XTT assay
|
Download PDF
|
|
KÖ PD-LTCs
|
50-100 nM
|
XTT assay
|
Download PDF
|
|
H3122
|
0.05 μM
|
MTT assay
|
PMC8636216
|
|
H2228
|
0.08 μM
|
MTT assay
|
PMC8636216
|
|
A549/R
|
30 –45μM
|
Cell Titer-Glo analysis reagent, microplate photoluminescence instrument, nonlinear regression of log to the response
|
Download PDF
|
|
H1299
|
15 –20μM
|
Cell Titer-Glo analysis reagent, microplate photoluminescence instrument, nonlinear regression of log to the response
|
Download PDF
|
|
3PAR
|
0.0080 µM
|
CellTiter 96 Aqueous Non-Radioactive Cell Proliferation Assay (MTS analysis)
|
PMC7653150
|
|
8PAR
|
0.016 µM
|
CellTiter 96 Aqueous Non-Radioactive Cell Proliferation Assay (MTS analysis)
|
PMC7653150
|
|
12PAR
|
0.015 µM
|
CellTiter 96 Aqueous Non-Radioactive Cell Proliferation Assay (MTS analysis)
|
PMC7653150
|
|
3CRR
|
>1 µM
|
CellTiter 96 Aqueous Non-Radioactive Cell Proliferation Assay (MTS analysis)
|
PMC7653150
|
|
8CRR
|
>1 µM
|
CellTiter 96 Aqueous Non-Radioactive Cell Proliferation Assay (MTS analysis)
|
PMC7653150
|
|
12CRR
|
>1 µM
|
CellTiter 96 Aqueous Non-Radioactive Cell Proliferation Assay (MTS analysis)
|
PMC7653150
|
|
BxPC3
|
15.60 µM
|
Cell viability studies
|
Download PDF
|
|
Capan 2
|
12.08 µM
|
Cell viability studies
|
Download PDF
|
|
Suit 2
|
18.97 µM
|
Cell viability studies
|
Download PDF
|
|
Suit 2
|
13.44 µM
|
Cell viability studies
|
Download PDF
|
|
Suit 2
|
11.46 µM
|
Cell viability studies
|
Download PDF
|
|
MIA PaCa-2
|
10.14 µM
|
Cell viability studies
|
Download PDF
|
|
MIA PaCa-2
|
6.41 µM
|
Cell viability studies
|
Download PDF
|
|
HNE-1 cells
|
0.79 ±0.21 µmol/L
|
Cell Counting Kit-8 (CCK-8)
|
PMC4555972
|
|
H1975
|
4 ± 0.1 µM
|
Sulforhodamine B assay
|
Download PDF
|
|
EBC-1
|
50 ± 2 nM
|
Sulforhodamine B assay
|
Download PDF
|
|
HCC827GR5
|
>5 µM
|
Sulforhodamine B assay
|
Download PDF
|
|
LoVo
|
13.6 ± 1.4 nM
|
clonogenic survival assay
|
PMC6226619
|
|
HCT116
|
315 ± 16 nM
|
clonogenic survival assay
|
PMC6226619
|
|
DLD1
|
217 ± 11 nM
|
clonogenic survival assay
|
PMC6226619
|
|
HCC78
|
100 nM
|
assay
|
Download PDF
|
|
JFCR-165
|
30 nM
|
assay
|
Download PDF
|
|
JFCR-168
|
30 nM
|
assay
|
Download PDF
|
|
MGH193-1B
|
30 nM
|
assay
|
Download PDF
|
|
KM12
|
>10000 nM
|
assay
|
Download PDF
|
|
MGH021-2 culture (CK8/18-positive cells)
|
1,300 nM
|
Immunofluorescence-based cell scoring (CK8/18-positive cell count)
|
Download PDF
|
|
MGH051-1 culture (CK8/18-positive cells)
|
60 nM
|
Immunofluorescence-based cell scoring (CK8/18-positive cell count)
|
Download PDF
|
|
MGH092-1 culture (CK8/18-positive cells)
|
166 nM
|
Immunofluorescence-based cell scoring (CK8/18-positive cell count)
|
Download PDF
|
|
COS
|
340 nM
|
MTS assay, Nonlinear regression using log-transformed values.
|
PMC4562978
|
|
033 T PDX cells
|
691 nmol/L
|
Cell viability analyzed using an adenosine triphosphate monitoring system based on firefly luciferase (ATPlite 1step); IC50 values calculated using S+ Chip Analyzer.
|
Download PDF
|
|
PC-9 rociletinib-resistant
|
1881 ± 159 nM
|
assay
|
Download PDF
|
|
NCI-H460
|
14.29 μM
|
MTT assay, Logit method
|
Download PDF
|
|
A549
|
11.25 μM
|
MTT assay, Logit method
|
Download PDF
|
|
IB112
|
8.7 mM
|
Luminescent Cell Viability Assay
|
PMC5729471
|
|
IB118
|
8.8 mM
|
Luminescent Cell Viability Assay
|
PMC5729471
|
|
IB133
|
7.5 mM
|
Luminescent Cell Viability Assay
|
PMC5729471
|
|
IB134
|
3.5 mM
|
Luminescent Cell Viability Assay
|
PMC5729471
|
|
IB136
|
7.0 mM
|
Luminescent Cell Viability Assay
|
PMC5729471
|
|
SK-LMS-1
|
4.2 mM
|
Luminescent Cell Viability Assay
|
PMC5729471
|
|
RH4
|
1.5 μM
|
MTT assay
|
Download PDF
|
|
RH30
|
1.5 μM
|
MTT assay
|
Download PDF
|
|
HCN4-expressing HEK-293 cells
|
1.4 ± 0.3 μmol/L
|
Whole-cell patch clamp technique
|
Download PDF
|
|
SK-N-BE(2)
|
3.80 μM
|
Alamar Blue assay
|
PMC5491461
|
|
SH-SY5Y
|
0.71 μM
|
Alamar Blue assay
|
PMC5491461
|
|
KELLY
|
0.83 μM
|
Alamar Blue assay
|
PMC5491461
|
|
CHLA-20
|
1.16 μM
|
Alamar Blue assay
|
PMC5491461
|
|
SK-N-AS
|
8.65 μM
|
Alamar Blue assay
|
PMC5491461
|
|
MKN45, Hs746t
|
< 57 nM
|
publicly available data from the Cancer Cell Line Encyclopedia (CCLE) project
|
Download PDF
|
|
SH-SY5Y
|
480.6 nM
|
Cell number estimated after cell fixation with 10% trichloroacetic acid and staining with sulforhodamine B in 1% acetic acid, calculated by nonlinear regression analysis using GRAPHPAD PRISM.
|
Download PDF
|
|
LAN-1
|
236.6 nM
|
Cell number estimated after cell fixation with 10% trichloroacetic acid and staining with sulforhodamine B in 1% acetic acid, calculated by nonlinear regression analysis using GRAPHPAD PRISM.
|
Download PDF
|
|
SK-N-SH
|
3059.5 nM
|
Cell number estimated after cell fixation with 10% trichloroacetic acid and staining with sulforhodamine B in 1% acetic acid, calculated by nonlinear regression analysis using GRAPHPAD PRISM.
|
Download PDF
|
|
Kelly
|
432.4 nM
|
Cell number estimated after cell fixation with 10% trichloroacetic acid and staining with sulforhodamine B in 1% acetic acid, calculated by nonlinear regression analysis using GRAPHPAD PRISM.
|
Download PDF
|
|
CLB-GA
|
167.6 nM
|
Cell number estimated after cell fixation with 10% trichloroacetic acid and staining with sulforhodamine B in 1% acetic acid, calculated by nonlinear regression analysis using GRAPHPAD PRISM.
|
Download PDF
|
|
LAN-5
|
132.0 nM
|
Cell number estimated after cell fixation with 10% trichloroacetic acid and staining with sulforhodamine B in 1% acetic acid, calculated by nonlinear regression analysis using GRAPHPAD PRISM.
|
Download PDF
|
|
IMR-32
|
511.7 nM
|
Cell number estimated after cell fixation with 10% trichloroacetic acid and staining with sulforhodamine B in 1% acetic acid, calculated by nonlinear regression analysis using GRAPHPAD PRISM.
|
Download PDF
|
|
A549 cells
|
(3.345±1.625) μmol/L
|
MTT assay, absorbance at 490 nm, SPSS 17.0 software for calculation.
|
Download PDF
|
|
HCC827
|
6.05 ± 0.11 µmol/L
|
Sulforhodamine B (SRB) assay, analyzed with WinNonlin software.
|
PMC5143436
|
|
EBC-1
|
0.054 ± 0.002 µmol/L
|
Sulforhodamine B (SRB) assay, analyzed with WinNonlin software.
|
PMC5143436
|
|
LUDLU-1
|
8.12 ± 0.28 µmol/L
|
Sulforhodamine B (SRB) assay, analyzed with WinNonlin software.
|
PMC5143436
|
|
Karpas 299
|
54.1 nM
|
Cell Counting Kit-8 (CCK-8)
|
PMC5912135
|
|
SU-DHL-1
|
53.4 nM
|
Cell Counting Kit-8 (CCK-8)
|
PMC5912135
|
|
OVCAR-3
|
0.21 μM
|
colorimetric assay using SRB
|
Download PDF
|
|
IGROV-1
|
0.26 μM
|
colorimetric assay using SRB
|
Download PDF
|
|
A2780
|
0.71 μM
|
colorimetric assay using SRB
|
Download PDF
|
|
SKOV-3
|
3.29 μM
|
colorimetric assay using SRB
|
Download PDF
|
|
EFO-21
|
4.37 μM
|
colorimetric assay using SRB
|
Download PDF
|
|
NB1643
|
0.5 μM
|
Dose-response curve analysis for cell viability
|
Download PDF
|
|
NB1
|
0.3 μM
|
Dose-response curve analysis for cell viability
|
Download PDF
|
|
SH-SY5Y
|
1 μM
|
Dose-response curve analysis for cell viability
|
Download PDF
|
|
NPM-ALK positive ALCL cell lines
|
24 nmol/L
|
cell-based selectivity assays
|
Download PDF
|
|
FC-IBC01
|
0.89 μM
|
ProMegaCellTiter Cell Proliferation Assay
|
Download PDF
|
|
Mary-X
|
0.87 μM
|
ProMegaCellTiter Cell Proliferation Assay
|
Download PDF
|
|
SUM149
|
0.77 μM
|
ProMegaCellTiter Cell Proliferation Assay
|
Download PDF
|
|
MDA-IBC-3
|
1.98 μM
|
ProMegaCellTiter Cell Proliferation Assay
|
Download PDF
|
|
SUM190
|
5.20 μM
|
ProMegaCellTiter Cell Proliferation Assay
|
Download PDF
|
|
KPL-4
|
6.45 μM
|
ProMegaCellTiter Cell Proliferation Assay
|
Download PDF
|
|
IMR-32 wt ALK
|
0.74 μM
|
ProMegaCellTiter Cell Proliferation Assay
|
Download PDF
|
|
SNU-620
|
16.4 nM
|
Standard metabolism-based anti-proliferative assays
|
PMC3950883
|
|
SNU-5
|
5.5 nM
|
Standard metabolism-based anti-proliferative assays
|
PMC3950883
|
|
Hs 746T
|
12.6 nM
|
Standard metabolism-based anti-proliferative assays
|
PMC3950883
|
|
GTL16
|
29.8 nM
|
Standard metabolism-based anti-proliferative assays
|
PMC3950883
|
|
SNU-638
|
12.2 nM
|
Standard metabolism-based anti-proliferative assays
|
PMC3950883
|
|
PAMC82
|
8254 nM
|
Standard metabolism-based anti-proliferative assays
|
PMC3950883
|
|
IM95m
|
133 nM
|
Standard metabolism-based anti-proliferative assays
|
PMC3950883
|
|
NUGC-3
|
5785 nM
|
Standard metabolism-based anti-proliferative assays
|
PMC3950883
|
|
OCUM-1
|
974 nM
|
Standard metabolism-based anti-proliferative assays
|
PMC3950883
|
|
SNU-601
|
2762 nM
|
Standard metabolism-based anti-proliferative assays
|
PMC3950883
|
|
NUGC-4
|
4575 nM
|
Standard metabolism-based anti-proliferative assays
|
PMC3950883
|
|
NCI-N87
|
5374 nM
|
Standard metabolism-based anti-proliferative assays
|
PMC3950883
|
|
SNU-216
|
5386 nM
|
Standard metabolism-based anti-proliferative assays
|
PMC3950883
|
|
MKN1
|
2090 nM
|
Standard metabolism-based anti-proliferative assays
|
PMC3950883
|
|
SNU-1
|
666 nM
|
Standard metabolism-based anti-proliferative assays
|
PMC3950883
|
|
MKN74
|
4754 nM
|
Standard metabolism-based anti-proliferative assays
|
PMC3950883
|
|
HGC-27
|
6942 nM
|
Standard metabolism-based anti-proliferative assays
|
PMC3950883
|
|
3132/87
|
1717 nM
|
Standard metabolism-based anti-proliferative assays
|
PMC3950883
|
|
AGS
|
1430 nM
|
Standard metabolism-based anti-proliferative assays
|
PMC3950883
|
|
SNU-484
|
2400 nM
|
Standard metabolism-based anti-proliferative assays
|
PMC3950883
|
|
AZ-521
|
1825 nM
|
Standard metabolism-based anti-proliferative assays
|
PMC3950883
|
|
KATO III
|
3122 nM
|
Standard metabolism-based anti-proliferative assays
|
PMC3950883
|
|
SNU-16
|
973 nM
|
Standard metabolism-based anti-proliferative assays
|
PMC3950883
|